What is CVE-2024-44837?

CVE-2024-44837 is a medium-severity vulnerability in Deathbreak Drug, classified under Cross-site Scripting. CVSS score: 5.4/10. Published 2024-09-06.

How severe is CVE-2024-44837?

Medium severity. CVSS v3 base score is 5.4 out of 10.

Is CVE-2024-44837 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

XSS in Deathbreak Drug

CVE-2024-44837

A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.

Vulnerability class: XSS (Cross-Site Scripting)

Published 2024-09-06 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 5.4 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N.

EPSS exploit prediction

EPSS: 0.003 (22.0th percentile), scored 2026-10-08.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 22nd percentile — 22.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: 0.000

Affected products

Deathbreak Drug — versions 1.0

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

Public proof-of-concept exploits

fkie-cad/nvd-json-data-feeds

References

kaput-raptorex-7c1.notion.site/drug-1-0-DOM-based-cross-site-scripting-fae620f7… (Exploit, Third Party Advisory)

Frequently asked questions

What is CVE-2024-44837?: CVE-2024-44837 is a medium-severity vulnerability in Deathbreak Drug, classified under Cross-site Scripting. CVSS score: 5.4/10. Published 2024-09-06.
How severe is CVE-2024-44837?: Medium severity. CVSS v3 base score is 5.4 out of 10.
Is CVE-2024-44837 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.